Paul and Diane Manning Institute of Biotechnology
Sector: Healthcare • Location: Charlottesville, Virginia, United States
Source: Modern Healthcare News
UVA Health is set to complete the $350 million, 350,000-square-foot Paul and Diane Manning Institute of Biotechnology in 2027. The institute aims to develop new treatments such as gene therapies for cancer, immune disorders, and neurological diseases, and to boost Virginia's biotech workforce and training pipeline.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | planned |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | UVA Health is set to complete the $350 million, 350,000-square-foot Paul and Diane Manning Institute of Biotechnology in 2027. The institute aims to develop new treatments such as gene therapies for cancer, immune disorders, and neurological diseases, and to boost Virginia's biotech workforce and training pipeline. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |